private

After a precipitous drop in early 2019, investor appetite for Asia-focused buyout funds appears to have made a comeback. With more cash in their bags, private equity funds, such as Hillhouse, CITIC Capital and MBK Partners, are gearing up to make big investments in 2020.

In partnership with China Investment Corporation (CIC) and BNP Paribas, Eurazeo’s China head tells FinanceAsia how France's largest private equity company plans to spend up to Eur1.5 billion to break into the world’s second largest economy.

Disruption caused by the fractious relationship between the world’s two biggest economies spells opportunity for the nimblest investors. Funds are looking to potentially bridge gaps in broken supply chains, take companies private and carve out Chinese units from MNCs.

As regulators crack down on fees, the private equity firm plans to focus the Korean credit card business company on its more profitable products.

The Fung family’s right-of-first-refusal is likely to disrupt the $1 billion sale of the toy retailer in Asia. Private equity bidders and distressed debt holders face disappointment.

Kolmar Korea goes up the value chain with the acquisition of CJ Healthcare to keep one step ahead of potential digital disruption in the sector.

TPG is expanding a Taiwanese clinical trial firm to help cut China's long queue for new drugs. The deal is another step in the private equity firm’s plan to create a pan-Asian CRO.

The private equity firm’s sale of its China Modern Dairy stake is nicely timed as it raises funds. But for buyer Mengnui the deal poses considerable integration risk.